Modifications of histones are known to play a role in cancer altering accessibility of DNA for transcriptional processes. So detection methods for enzymes modifying histones are of urgent need. We established two hybridoma cell lines producing antibodies suitable for immunocytochemistry, chromatin IP, but also Western Blot.
Further Information: PDF
Deutsches Krebsforschungszentrum DKFZ
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
